Researches

Displaying 181 - 190 of 3979
# Title Department Research Year
181 Surface engineering of carbon microspheres with nanoceria wrapped on MWCNTs: a dual electrocatalyst for simultaneous monitoring of molnupiravir and paracetamol Department of Pharmaceutical Analytical Chemistry 2024
182 Sustainable and efficient monitoring of tryptophan and tyrosine serum levels: a green HPTLC method as a biomarker for type 2 diabetes Department of Pharmaceutical Analytical Chemistry 2024
183 Synergistic effects of quercetin-loaded CoFe2O4@Liposomes regulate DNA damage and apoptosis in MCF-7 cancer cells: based on biophysical magnetic hyperthermia Department of Industrial Pharmacy 2024
184 Synthesis and characterization of new palladium (II) and silver (I) thiosemicarbazone derived by acenaphthenequinone complexes and their antimicrobial activity Department of Pharmaceutical Organic Chemistry 2024
185 Synthesis new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2024
186 Synthesis, enzyme inhibition, and docking studies of new Schiff bases of disalicylic acid methylene-based derivatives as dual-target antibacterial agents Department of Pharmaceutical Organic Chemistry 2024
187 Tetrahydro-(2H)-1,3,5-thiadiazine-2-thione (THTT), A Versatile Carrier System for Targeting Cell Cycle Checkpoint Pathways with Potential Anticancer Activities Department of Medicinal Chemistry 2024
188 Tetrahydrocarbazoles incorporating 5-arylidene-4-thiazolinones as potential antileukemia and antilymphoma targeting tyrosine kinase and tubulin polymerase enzymes: Design, synthesis, structural, biological and molecular docking studies Department of Pharmaceutical Organic Chemistry 2024
189 The promising antioxidant effects of lignans: Nrf2 activation comes into view Department of Pharmacognosy 2024
190 Therapeutic effects of myrrh extract and myrrh-based silver nanoparticles on Trichinella spiralis-infected mice: parasitological, histopathological, and immunological (IFN-γ, IL-10, and MMP-9) investigations 2024